Mahamaya Lifesciences Limited (BOM:544611)
180.00
-5.00 (-2.70%)
At close: Jan 16, 2026
Mahamaya Lifesciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 41.99 | 39.16 | 30.15 | 30.44 | 13.65 |
Cash & Short-Term Investments | 41.99 | 39.16 | 30.15 | 30.44 | 13.65 |
Cash Growth | - | 29.89% | -0.98% | 122.99% | - |
Accounts Receivable | 624.88 | 484.63 | 283.09 | 95.28 | 91.06 |
Other Receivables | - | 2.21 | 0.89 | 0.58 | 0.16 |
Receivables | 680.42 | 486.83 | 283.98 | 95.86 | 91.23 |
Inventory | 1,319 | 1,006 | 516.37 | 369.52 | 191.76 |
Prepaid Expenses | - | 1.95 | 0.92 | 0.6 | 0.64 |
Other Current Assets | 4.35 | 32.77 | 41.76 | 43.59 | 35.96 |
Total Current Assets | 2,045 | 1,567 | 873.18 | 540.01 | 333.24 |
Property, Plant & Equipment | 211.24 | 217.4 | 183.26 | 177.76 | 170.58 |
Other Intangible Assets | 97.3 | 41.21 | 29.56 | 35.3 | 40.62 |
Long-Term Deferred Tax Assets | - | - | - | - | 1.05 |
Long-Term Deferred Charges | 4.54 | 53.12 | 31.68 | 22.48 | 8.32 |
Other Long-Term Assets | 4.33 | 4.49 | 3.3 | 3.29 | 3.34 |
Total Assets | 2,363 | 1,883 | 1,121 | 778.83 | 557.13 |
Accounts Payable | 774.95 | 550.68 | 226.58 | 276.45 | 165.56 |
Accrued Expenses | 279.56 | 182.88 | 41.56 | 12.7 | 15.36 |
Short-Term Debt | 637.07 | 487.55 | 433.43 | 115.56 | 78.73 |
Current Portion of Long-Term Debt | - | 31.2 | 27.35 | 25.16 | 16.13 |
Current Income Taxes Payable | - | 33.57 | 14.8 | 9.34 | 9.21 |
Other Current Liabilities | 34.92 | 29.6 | 36.25 | 37.43 | 15.17 |
Total Current Liabilities | 1,727 | 1,315 | 779.97 | 476.64 | 300.16 |
Long-Term Debt | 46.03 | 61.6 | 85.48 | 103 | 96.79 |
Pension & Post-Retirement Benefits | - | 3.29 | 2.72 | 2.27 | 2.46 |
Long-Term Deferred Tax Liabilities | 8.77 | 7.07 | 4.14 | 1.73 | - |
Other Long-Term Liabilities | 4.6 | 1.1 | 0.81 | 0.8 | 0.65 |
Total Liabilities | 1,786 | 1,389 | 873.11 | 584.44 | 400.06 |
Common Stock | 177.66 | 177.66 | 12.49 | 12.49 | 12.49 |
Additional Paid-In Capital | - | 100.31 | - | - | - |
Retained Earnings | - | 216.53 | 235.24 | 181.78 | 144.27 |
Comprehensive Income & Other | 399.13 | -0.3 | 0.14 | 0.13 | 0.31 |
Shareholders' Equity | 576.79 | 494.2 | 247.86 | 194.4 | 157.06 |
Total Liabilities & Equity | 2,363 | 1,883 | 1,121 | 778.83 | 557.13 |
Total Debt | 683.1 | 580.35 | 546.26 | 243.73 | 191.65 |
Net Cash (Debt) | -641.11 | -541.19 | -516.11 | -213.28 | -178 |
Net Cash Per Share | -36.10 | -31.87 | -37.57 | -15.53 | -12.96 |
Filing Date Shares Outstanding | 17.77 | 17.77 | 13.74 | 13.74 | 13.74 |
Total Common Shares Outstanding | 17.77 | 17.77 | 13.74 | 13.74 | 13.74 |
Working Capital | 318.79 | 251.04 | 93.21 | 63.37 | 33.08 |
Book Value Per Share | 32.46 | 27.82 | 18.04 | 14.15 | 11.43 |
Tangible Book Value | 479.49 | 452.99 | 218.3 | 159.09 | 116.44 |
Tangible Book Value Per Share | 26.98 | 25.50 | 15.89 | 11.58 | 8.48 |
Land | - | 38.54 | 41.04 | 41.04 | 41.04 |
Buildings | - | 111.3 | 98.38 | 97.58 | 94.14 |
Machinery | - | 112.08 | 81.88 | 71.05 | 59.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.